Training and Educational Opportunities
Inspiring and Training the Next Generation of Great Minds
MCI is committed to developing the next generation of outstanding researchers to continue the battle against cancer. We offer a variety of programs centered in basic and translational cancer biology research, including High School and Undergraduate Student Outreach, a Doctoral Program in Cancer Biology and a robust Postdoctoral Training Program.
Data in Progress
MCI also offers weekly Data in Progress presentations wherein postdoctoral students and Research Principal Investigators as well as guest researchers present the status of their current and on-going research. Data in Progress presentations are offered each Tuesday at 4:00-5:00 p.m. in the MCI Multipurpose Room.
- Special Date: Friday, 02/17/17 -- Mitochondria matter: targeting mitochondrial function in tumor cells, Bennett Van Houten, Ph.D.
- 02/21/17 -- Aberrant glycosylation of MUC16 enhances the malignant properties of pancreatic cancer cells, Prakash Radhakrishnan, Ph.D.
- 03/07/17 -- A new approach to understanding racial disparities in prostate cancer, Nallaisvam Palanisamy, Ph.D.
- 01/24/17 -- Role of SON in Down Syndrome Acute Megakaryoblastic Leukemia, Eun-young Park, Ph.D.
- 01/10/17 -- Risky Tanning Behaviors among Adolescents and Young Adults: Opportunities for Intervention and Prevention, Casey Daniel, Ph.D.
- 01/03/17 -- SON-mediated alternative RNA splicing in glioblastoma, Dr. Jung-Hyun Kim
- 12/20/16 -- Investigating tumor intrinsic functions of B7-H3 in ovarian cancer, Dr. Luciana Barnes
- 12/06/16 -- IKK-epsilon promotes pancreatic tumor growth by modulating cancer metabolism through c-MYC, Haseeb Zubair, Ph.D.
- 11/29/16 -- MYB rearrangements in head and neck adenoid cystic carcinoma, Mariana Brait, Ph.D.
- 11/18/16 -- Small business funding at the National Cancer Institute: Helping scientific innovators move discoveries towards the marketplace, Kory Hallett, Ph.D., Program Manager, SBIR-National Cancer Institute
- 11/15/16 -- UBE3B is a calmodulin-regulated, mitochondria-associated E3 ubiquitin ligase, Robert W. Sobol, Ph.D.
- 11/08/16 -- Investigations of herbal medicines as adjuvants in chemotherapy, Greg Gorman, Ph.D.
- 11/03/16 -- Radiotracer development for PET imaging of PDE10, Jinda Fan, Ph.D.
- 10/25/16 -- The regulation and functional role of MALAT1, a long non-coding RNA, in breast cancer, Joshua Stone, Ph.D.
- 10/18/16 -- Sunless tanning: A better alternative to indoor tanning?, Natalie Gassman, Ph.D.
- 10/04/16 -- miR-125b regulates differentiation and metabolic reprogramming of T cell acute lymphoblastic leukemia by directly targeting A20, Zixing Liu, Ph.D.
- 09/20/16 -- Rad6-mediated ubiquitin signaling in the etiology and therapeutics of ovarian cancer, Sebastian Spencer, Ph.D.
- 09/06/16 -- An overview of then next generation high capacity cometchip DNA damage detection assay, Peter Sykora, Ph.D.
- 08/09/16 -- Visualize the RNA World Next generation RNA ISH Technology, Arthur Haynes
- 07/26/16 -- Chemopreventive role of silver nanoparticles (AgNPs) in UVB radiation-induced skin cancer, Nikhil Tyagi
- 07/19/16 -- B7H3 regulates cancer stem cell through MVP signal transduction pathway, Zixing Liu, Ph.D.
Distinguished Scientist Seminar
MCI participates in the Distinguished Scientist Seminar series with the USA College of Medicine. National and international scientists and researchers are invited to host seminars that discuss their current and on-going research activities. Mitchell Cancer Institute sponsors several scientist/researchers during the year. Distinguished Scientist Seminars are offered on Thursdays at 4:00-5:00 p.m. in the first-floor auditorium at the USA College of Medicine's Medical Sciences Building.